Danaparoid and multi-organ failure Patient Reports February 12, 2012

Danaparoid Side Effects Report #6085320-X
Danaparoid side effect was reported by a Physician from FRANCE on Feb 13, 2009. Male patient, 80 years of age, was diagnosed with thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: arterial thrombosis limb, femoral artery occlusion, haematoma, heparin-induced thrombocytopenia, multi-organ failure, peripheral ischaemia, renal failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN, AMIODARONE, FUROSEMIDE, AUGMENTIN, ACETYLSALICYLATE LYSINE. Patient died.

Danaparoid Side Effects Report #5139587-2
Danaparoid side effect was reported by a Health Professional from AUSTRALIA on Oct 17, 2006. Male patient, 60 years of age, was diagnosed with heparin-induced thrombocytopenia and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: dialysis device complication, multi-organ failure, platelet count decreased, thrombosis in device. Danaparoid dosage: unknown. During the same period patient was treated with LEPIRUDIN, HEPARIN. Patient died.

Danaparoid Side Effects Report #5093082-8
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 79 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: multi-organ failure, shock haemorrhagic. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, MEROPENEM TRIHYDRATE, CLINDAMYCIN PHOSPHATE, VANCOMYCIN HYDROCHLORIDE, IMMUNE GLOBULIN INTRAVENOUS, FAMOTIDINE, CARPERITIDE. Patient died.

Danaparoid Side Effects Report #5035199-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 16, 2006. Female patient, 79 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: multi-organ failure, shock haemorrhagic. Danaparoid dosage: unknown. During the same period patient was treated with AMPICILLIN, MEROPENEM TRIHYDRATE, CLINDAMYCIN PHOSPHATE, VANCOMYCIN HYDROCHLORIDE, IMMUNE GLOBULIN INTRAVENOUS, FAMOTIDINE, CARPERITIDE. Patient died.


Danaparoid Side Effects Report #5108484-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 18, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, condition aggravated, gastrointestinal haemorrhage, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5110463-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Aug 11, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #5116971-4
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 15, 2006. Female patient, 78 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, gastrointestinal haemorrhage, multi-organ failure, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with MEROPENEM TRIHYDRATE, FAMOTIDINE, CLINDAMYCIN PHOSPHATE, PAZUFLOXACIN, HYDROCORTISONE SUCCINATE, MICAFUNGIN, GABEXATE MESILATE, CARPERITIDE. Patient was hospitalized. Patient recovered.

Danaparoid Side Effects Report #4975619-X
Danaparoid side effect was reported by a Health Professional from JAPAN on Mar 23, 2006. Female patient, 76 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: asthma , blood bilirubin increased, blood potassium increased, disseminated intravascular coagulation, emphysema, haematocrit decreased, haemoglobin decreased, multi-organ failure, red blood cell count decreased. Danaparoid dosage: unknown. During the same period patient was treated with PANCURONIUM BROMIDE, GABEXATE MESILATE, CEFOZOPRAN HYDROCHLORIDE, THEOPHYLLINE, PROPOFOL. Patient died on 09/29/2003.

Danaparoid Side Effects Report #5129253-1
Danaparoid side effect was reported by a Health Professional from JAPAN on June 01, 2006. Male patient, 64 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: concomitant disease aggravated, haemorrhage subcutaneous, hepatic failure, multi-organ failure, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FUROSEMIDE, DOPAMINE, POTASSIUM CANRENOATE, CEFTAZIDIME, NAFAMOSTAT MESILATE. Patient died.


Danaparoid Side Effects Report #5124726-X
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 05, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5024837-3
Danaparoid side effect was reported by a Consumer or non-health professional from UNITED ARAB EMIRATES on June 01, 2006. Female patient, 58 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, oliguria, renal impairment, sepsis , septic shock. Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, FINIBAX, IMMUNE GLOBULIN INTRAVENOUS, HYDROCORTISONE PHOSPHATE. Patient died.

Danaparoid Side Effects Report #5153401-0
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 57 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, haemoglobin decreased, haemorrhage, hepatic function abnormal, multi-organ failure, neoplasm malignant, renal impairment. Danaparoid dosage: unknown. During the same period patient was treated with GABEXATE MESILATE, NAFAMOSTAT MESILATE, DOPAMINE, OMEPRAZOLE, CEFOZOPRAN HYDROCHLORIDE, ANTITHROMBIN III, ULINASTATIN. Patient died.

Danaparoid Side Effects Report #5116965-9
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Sept 19, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: condition aggravated, disseminated intravascular coagulation, haemolytic anaemia, hepatic function abnormal, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, CILASTATIN W, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.

Danaparoid Side Effects Report #5024833-6
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on June 01, 2006. Male patient, 36 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: disease progression, disseminated intravascular coagulation, haemolytic anaemia, multi-organ failure, pancreatitis acute, sepsis . Danaparoid dosage: unknown. During the same period patient was treated with ANTITHROMBIN III, ULINASTATIN, TIENAM, NAFAMOSTAT MESILATE, HYDROCORTISONE PHOSPHATE, IMMUNE GLOBULIN INTRAVENOUS. Patient died.


Danaparoid Side Effects Report #5148279-5
Danaparoid side effect was reported by a Consumer or non-health professional from JAPAN on Oct 30, 2006. Male patient, 17 years of age, was diagnosed with disseminated intravascular coagulation and was treated with Danaparoid. After drug was administered, patient experienced the following side effects: activated partial thromboplastin time prolonged, condition aggravated, gastrointestinal haemorrhage, multi-organ failure. Danaparoid dosage: unknown. During the same period patient was treated with DOPAMINE, CEFPIROME SULPHATE, ANTITHROMBIN III, FAMOTIDINE, METHYLPREDNISOLONE SUCCINATE, ULINASTATIN, OMEPRAZOLE, GABEXATE MESILATE. Patient died.

Danaparoid Side Effects Report #4932635-1
Danaparoid side effect was reported by a Health Professional from FRANCE on Feb 21, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: anti-platelet antibody positive, catheter site haemorrhage, gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, renal failure. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.

Danaparoid Side Effects Report #4939443-6
Danaparoid side effect was reported by a Consumer or non-health professional from FRANCE on Feb 27, 2006. Female patient, 78 years of age, was treated with Danaparoid. After drug was administered, patient experienced the following side effects: gastrointestinal haemorrhage, haematoma, haemothorax, leukocytosis, multi-organ failure, platelet count decreased, post procedural haemorrhage. Danaparoid dosage: unknown. During the same period patient was treated with HEPARIN. Patient was hospitalized. Patient died.